Order results by:
| Issue | Title | |
| Vol 16, No 1 (2023) | Prospects for using high-throughput sequencing methods to identify new biomarkers of response and resistance to antitumor therapy | Abstract similar documents |
| M. А. Sorokina, T. R. Grishina | ||
| "... ) and bulk RNA sequencing (RNA-seq) allow identification of the new biomarkers of response and resistance ..." | ||
| Vol 13, No 2 (2020) | COVID-19 pandemic: protective role of vitamin D | Abstract similar documents |
| O. A. Gromova, I. Yu. Torshin, G. Kh. Gabdulina | ||
| "... RNA viruses (interferon-dependent protection). The results of the systematic analysis ..." | ||
| Vol 15, No 2 (2022) | Clinical study of real-time polymerase chain reaction test kit for SARS-CoV-2 ribonucleic acids detection | Abstract similar documents |
| M. Yu. Dmitryukova, A. A. Golod, M. E. Senina, A. E. Gushchin | ||
| "... ) test kit for SARS-CoV-2 ribonucleic acids (RNA) qualitative detection adapted for using with automated ..." | ||
| Vol 14, No 1 (2021) | Development of a method for the analysis of the lists of medicines and its application for the analysis of the lists of medicines in Russia, England, and Italy | Abstract similar documents |
| V. A. Lemeshko, K. I. Matrenin, V. V. Omelyanovskiy, Yu. V. Vasilyeva, G. R. Khachatryan, L. A. Kolganov | ||
| "... апробации методики выбраны национальные перечни России, Англии и Италии. Предложено использовать три ..." | ||
| Vol 16, No 2 (2023) | New pharmacotherapeutic approaches for the treatment of peripheral T-cell lymphoma | Abstract similar documents |
| M. А. Sorokina, A. V. Rakhteenko, T. R. Grishina | ||
| "... . The literature highlights the importance of using biomarkers obtained from whole exome sequencing and tumor ..." | ||
| Vol 17, No 4 (2024) | Scenario modeling of the drug prescription process for children: application of machine learning methods | Abstract similar documents |
| А. А. Kondrashov, М. М. Kurashov, Е. Е. Loskutova | ||
| "... валидированы модели следующих архитектур: полносвязная нейронная сеть (англ. fully connected neural network ..." | ||
| Vol 14, No 1 (2021) | Review of foreign experience in the implementation of eHealth | Abstract similar documents |
| P. V. Minaev, D. V. Fedyaev, Yu. V. Seryapina, T. V. Skomorokhova | ||
| "... медицинская карта (англ. Electronic Health Record, EHR), Обмен медицинской информацией (англ. Health ..." | ||
| Vol 14, No 1 (2021) | History of controlled trials in medicine: real priorities are little-known. Report 1. Basic concepts, terms, and disciplines that use medical experiment: historical and philosophical sources | Abstract similar documents |
| A. N. Koterov, O. A. Tikhonova, L. N. Ushenkova, A. P. Biryukov | ||
| "... (англ. controlled trials, CT) и рандомизированных контролируемых испытаний (англ. randomized controlled ..." | ||
| Vol 15, No 3 (2022) | The role of real world data and real world evidence in health technology assessment | Abstract similar documents |
| E. A. Novoderezhkina, S. К. Zyryanov | ||
| "... В современном мире область данных, собираемых в условиях реальной клинической практики (РКП; англ ..." | ||
| Vol 16, No 4 (2023) | DMOADs and DMARDs in the treatment of patients with joint and spine diseases | Abstract PDF (Eng) similar documents |
| O. A. Shavlovskaya | ||
| "... остеоартрит препараты (англ. disease-modifying osteoarthritis drugs, DMOADs) и болезнь-модифицирующие ..." | ||
| Vol 11, No 4 (2018) | International experience in determining the cost-effectiveness thresholds | Abstract similar documents |
| T. P. Bezdenezhnykh, N. Z. Musina, V. K. Fedyaeva, T. S. Tepcova, V. A. Lemeshko, V. V. Omelyanovsky | ||
| "... the ICeR) в странах Европы (Англия и Уэльс, Шотландия, Ирландия, Франция, Бельгия, Дания, Нидерланды ..." | ||
| Vol 17, No 1 (2024) | Analysis of the availability of bronchodilators and anti-inflammatory drugs for patients with chronic obstructive pulmonary disease | Abstract PDF (Eng) similar documents |
| E. A. Orlova, V. I. Petrov, I. P. Dorfman, O. V. Shatalova, M. A. Orlov | ||
| "... здоровье и здравоохранение» (англ. Health Action International, HAI). Оценивали бронхолитическую и ..." | ||
| Vol 17, No 3 (2024) | Chemoproteomic analysis of the pharmacological properties of vitamin В12 derivatives | Abstract similar documents |
| I. Yu. Torshin, O. A. Gromova, I. A. Dereven’kov, L. A. Maiorova | ||
| "... топологического анализа данных, проведены оценки констант концентрации полумаксимального ингибирования (англ. half ..." | ||
| Vol 15, No 1 (2022) | Efficacy of targeted drugs for the treatment of adults with moderate-to-severe plaque psoriasis in the Russian Federation: a systematic literature review update | Abstract similar documents |
| V. D. Sokolova, N. A. Sableva, V. V. Mladov, D. G. Tolkacheva | ||
| "... (англ. number needed to treat, NNT) для достижения ответа на терапию, и затрат на его достижение (англ ..." | ||
| Vol 17, No 3 (2024) | Cystatin C: factors affecting diagnostic and prognostic value in acute kidney injury | Abstract similar documents |
| M. O. Magomedaliev, D. I. Korabelnikov | ||
| "... глюкокортикостероидов оказывают влияние на концентрацию цистатина С (англ. cystatin C, CysC) в сыворотке крови и моче ..." | ||
| Vol 12, No 2 (2019) | Organizational structure and funding of health technology assessment agencies around the world | Abstract similar documents |
| G. R. Khachatryan, V. V. Omelyanovskiy, L. S. Melnikova, S. S. Ratushnyak | ||
| "... , Уэльсе и Северной Ирландии у Национального Института здоровья и клинического совершенствования (англ ..." | ||
| Vol 14, No 3 (2021) | COVID-19 pandemic prediction model based on machine learning in selected regions of the Russian Federation | Abstract similar documents |
| D. V. Gavrilov, R. V. Abramov, А. V. Kirilkina, А. А. Ivshin, R. E. Novitskiy | ||
| "... учетом ошибки предсказания в процентах (англ. mean absolute percentage error, MAPE) составляет от 2,3% до ..." | ||
| Vol 16, No 2 (2023) | Pharmacoeconomic analysis of tixagevimab and cilgavimab combination for COVID-19 therapy | Abstract similar documents |
| M. V. Zhuravleva, V. P. Chulanov, Yu. V. Gagarina, E. A. Shabalina | ||
| "... TACKLE. Рассчитывали количество сохраненных лет жизни (англ. life years gained, LYG), а также количество ..." | ||
| Vol 16, No 2 (2023) | Pharmacoeconomic study of various treatment options for superficial vein thrombophlebitis of lower extremities | Abstract similar documents |
| R. E. Kalinin, I. A. Suchkov, M. M. Uporov, D. S. Titov, M. Yu. Klishchenko | ||
| "... –эффективность» (англ. сosteffectiveness analysis, CEA), рассчитывая коэффициент «затраты–эффективность» (англ ..." | ||
| Vol 16, No 4 (2023) | Comparative chemomicrobiomic analysis of bacteriocins | Abstract similar documents |
| I. Yu. Torshin, O. A. Gromova | ||
| "... ингибирующих концентраций (англ. minimum inhibitory concentration, MIC) для 152 штаммов болезнетворных бактерий ..." | ||
| Vol 16, No 4 (2023) | Analysis of the clinical and economic effectiveness of using benralizumab in comparison with standard therapy in patients with severe bronchial asthma | Abstract similar documents |
| S. V. Nedogoda, A. S. Salasyuk, S. N. Avdeev, I. N. Barykina, V. O. Lutova, E. A. Popova | ||
| "... ,65 добавленного года жизни (англ. life year gained, LYG) и 1,12 года жизни с поправкой на качество (англ. quality ..." | ||
| Online First | Implementation of modern quality management system requirements in the production management of reference standards for pharmaceuticals and medicine | Abstract similar documents |
| V. I. Gegechkori, A. M. Sukhanova, N. O. Belyavskiy, G. V. Ramenskaya | ||
| "... также принципы надлежащей производственной практики (англ. good manufacturing practice, GMP) и ..." | ||
| Vol 14, No 3 (2021) | History of controlled trials in medicine: real priorities are little-known. Report 2. From early experiments to the present day: without alternation and randomization | Abstract similar documents |
| A. N. Koterov, O. A. Tikhonova, L. N. Ushenkova, A. P. Biryukov | ||
| "... испытаний (англ. controlled trials, CT) и рандомизированных контролируемых испытаний (англ. randomized ..." | ||
| Vol 14, No 4 (2021) | Peptides of Laennec® preparation that contribute to the elimination of endotheliopathy | Abstract similar documents |
| I. Yu. Torshin, О. А. Gromova, V. G. Zgoda, А. G. Chuchalin, V. А. Maksimov, О. V. Tikhonova | ||
| "... sequencing of the isolated peptides. Results. The preparation contains peptides-inhibitors of specific target ..." | ||
| Vol 16, No 4 (2023) | Nephroprotective peptides of Laennec® in the context of pharmacotherapy for nephro-hepato-metabolic disorders | Abstract similar documents |
| O. A. Gromova, I. Yu. Torshin, A. N. Gromov, O. V. Tikhonova | ||
| "... of the multidimensional mass spectrum of peptide fraction and de novo sequencing of the isolated peptides. Results ..." | ||
| Vol 12, No 2 (2019) | Health technology assessment and reimbursement of pharmaceuticals in Italy | Abstract similar documents |
| F. V. Gorkavenko, V. V. Omelyanovskiy, T. P. Bezdenezhnykh, G. R. Khachatryan | ||
| "... развитии между северными и южными регионами страны. Медицинское агентство Италии (англ ..." | ||
| Vol 12, No 4 (2019) | The health technology assessment system in Australia | Abstract similar documents |
| V. V. Omelyanovskiy, E. S. Saybel, T. P. Bezdenezhnykh, G. R. Khachatryan | ||
| "... к федеральным. Консультативный Комитет по фармацевтическим льготам (англ. – Pharmaceutical Benefits ..." | ||
| Vol 16, No 1 (2023) | Cost-effectiveness analysis of using atorvastatin, simvastatin, ezetimibe, alirocumab, evolocumab, inclisiran in adults with very high cardiovascular risk under the preferential drug provision program | Abstract similar documents |
| T. O. Bessonova, P. A. Mukhortova, R. A. Teryan, A. D. Bagdasarov, N. Z. Musina | ||
| "... год. В качестве исходов были использованы годы жизни с поправкой на качество (англ. quality-adjusted ..." | ||
| Vol 16, No 3 (2023) | Disease-modifying osteoarthritis drugs (DMOADs): new trends in osteoarthritis therapy | Abstract similar documents |
| O. A. Shavlovskaya, О. А. Gromova, A. Yu. Kochish, Yu. D. Yukhnovskaya, I. D. Romanov, I. A. Bokova | ||
| "... потенциальных болезнь модифицирующих остеоартрит препаратов (англ. disease-modifying osteoarthritis drugs ..." | ||
| Vol 16, No 3 (2023) | Possibilities of using coenzyme Q10 for the treatment of diseases associated with mitochondrial dysfunction and chronic inflammation | Abstract similar documents |
| O. A. Gromova, I. Yu. Torshin, A. N. Gromov | ||
| "... Актуальность. Ферментативный кофактор коэнзим Q10 (англ. coenzyme Q10, CoQ10) участвует в синтезе ..." | ||
| Vol 17, No 2 (2024) | Cystatin C: diagnostic and prognostic value in acute kidney injury | Abstract similar documents |
| D. I. Korabelnikov, M. O. Magomedaliev | ||
| "... прогностические возможности цистатина С (англ. cystatin C, CysC) при ОПП. Проанализированы результаты 55 ..." | ||
| Vol 18, No 2 (2025) | IgA nephropathy: predicting the risks of progression | Abstract similar documents |
| D. I. Korabelnikov, M. E. Mantsaeva | ||
| "... Иммуноглобулин А-нефропатия (англ. immunoglobulin A, IgA) является наиболее распространенной ..." | ||
| Vol 15, No 4 (2022) | Dietary factors influencing the COVID-19 epidemic process | Abstract PDF (Eng) similar documents |
| S. V. Ponomarenko | ||
| "... частотой заболеваемости (англ. rate of prevalence, RPr) и смертности (англ. infection fatality rate, IFR) в ..." | ||
| Vol 14, No 4 (2021) | Analysis of the consumption volumes of antithrombotic drugs used for pharmacotherapy of atrial fibrillation in Saratov Region | Abstract similar documents |
| А. V. Sokolov, О. V. Reshet’ko | ||
| "... фибрилляции предсердий (ФП), применяя методологии анализа установленных суточных доз (англ. ATC/DDD ..." | ||
| Vol 14, No 4 (2021) | Economic burden of chronic viral hepatitis C | Abstract similar documents |
| R. A. Yakhina, I. A. Lakman, D. A. Valishin, R. Kh. Bakhitova | ||
| "... % рассмотренных публикаций использовались инструменты с поправкой бремени на качество жизни: QALY (англ. quality ..." | ||
| Vol 16, No 2 (2023) | Pharmacoepidemiological and drug interaction analysis in the treatment of chronic renal and hepatic failure | Abstract similar documents |
| O. V. Zhukova, D. S. Fokina, O. V. Ruina, M. V. Khazov | ||
| "... ATC/DDD (англ. anatomical therapeutic chemical (ATC) classification system – анатомо-терапевтическо ..." | ||
| Vol 16, No 3 (2023) | Updated pharmacoeconomic analysis of atesolizumab efficiency compared with other PD-1 inhibitors in patients with advanced non-small cell lung cancer after chemotherapy | Abstract similar documents |
| S. K. Zyryanov, I. N. Dyakov | ||
| "... лиганда рецептора программируемой клеточной гибели 1 (англ. рrogrammed death ligand 1, PD-L1)) в сравнении ..." | ||
| Vol 17, No 4 (2024) | Pharmacoeconomic analysis of netakimab in the treatment of ankylosing spondylitis: perspective of Russian healthcare system | Abstract similar documents |
| A. V. Rudakova, I. Z. Gaydukova | ||
| "... ответа на лечение по шкале Международного общества по изучению спондилоартрита (англ. Аssessment of ..." | ||
| Vol 12, No 3 (2019) | Pharmacoepidemiological analysis of antimicrobial therapy for burn injury in the hospital settings | Abstract similar documents |
| O. V. Zhukova, E. S. Nekaeva, E. S. Khoroshavina, E. A. Kozlova, Yu. A. Dudukina, I. Yu. Arefyev | ||
| "... использовались DDD-анализ (англ. – Defined Daily Dose – установленная суточная доза) – анализ фактического ..." | ||
| Vol 15, No 3 (2022) | Economic burden of the novel coronavirus infection: a systematic review | Abstract similar documents |
| V. M. Timiryanova, I. A. Lakman, N. Sh. Zagidullin, D. F. Gareeva | ||
| "... предполагают расчет потерянных лет жизни с поправкой на качество (англ. quality-adjusted life years, QALY) (66 ..." | ||
| Vol 14, No 4 (2021) | History of controlled trials in medicine: real priorities are little-known. Report 3. Quasi-randomized and randomized trials in humans and animals | Abstract similar documents |
| A. N. Koterov, O. A. Tikhonova, L. N. Ushenkova, A. P. Biryukov | ||
| "... испытаний (англ. Controlled trials, CT) и рандомизированных контролируемых испытаний (англ. randomized ..." | ||
| Vol 18, No 1 (2025) | Comparative estimation of the effectiveness of the Khorana, Vienna CATS, and TiC-Onco scores and the vWF/ADAMTS13 ratio in identifying a high risk of thrombotic complications in patients with malignant neoplasms | Abstract similar documents |
| A. V. Vorobеv, A. G. Solopova, V. O. Bitsadze, M. M. Baeva, M. E. Sosnyagova, V. N. Galkin, D. O. Utkin, A. D. Makatsariya | ||
| "... -Onco, а также измеряли уровни фактора фон Виллебранда (англ. von Willebrand factor, vWF) и фермента ..." | ||
| Vol 17, No 4 (2024) | Pharmacoeconomic study of active psoriatic arthritis treatment | Abstract similar documents |
| A. V. Rudakova, Т. V. Korotaeva | ||
| "... изменение суставных симптомов по критерию Американской коллегии ревматологов (англ. Аmerican Сollege of ..." | ||
| Vol 15, No 3 (2022) | Drug therapy for obesity in the Russian Federation: pharmacoepidemiological study | Abstract similar documents |
| V. V. Strizheletsky, Yu. М. Gomon, Е. А. Spichakova, А. S. Kolbin, А. А. Kalyapin, S. А. Makarov, А. B. Lomiya, F. М. Sultanova | ||
| "... объемов каждого препарата в количество средних установленных суточных доз (англ. defined daily dose, DDD ..." | ||
| Vol 15, No 2 (2022) | Pharmacoeconomic analysis of the use of a fixed combination of tiotropium bromide and olodaterol as maintenance therapy in patients with chronic obstructive pulmonary disease in the Russian Federation | Abstract similar documents |
| S. К. Zyryanov, I. N. Dyakov | ||
| "... Глобальной инициативы по борьбе с хронической обструктивной болезнью легких (англ. Global Initiative for ..." | ||
| Vol 15, No 2 (2022) | Pharmacoeconomic study of the treatment of arterial hypertension in children and adolescents using cost-of-illness analysis | Abstract similar documents |
| O. S. Mikhaylova, A. V. Krikova | ||
| "... Актуальность. Метод анализа стоимости болезни (англ. cost of illness, COI) позволяет оценить и ..." | ||
| Vol 16, No 1 (2023) | Efficiency of Levilimab in patients with moderate and severe COVID-19 | Abstract similar documents |
| Yu. M. Gomon, V. V. Strizheletsky, I. G. Ivanov, Yu. E. Balykina, M. V. Ermolyev, A. S. Kolbin, M. V. Livshits, T. A. Usmanova, A. M. Fakhrutdinova, Yu. S. Konstantinova, A. P. Gubanov | ||
| "... практики (англ. real world data, RWD). Материал и методы. Проведено одноцентровое наблюдательное ..." | ||
| Vol 15, No 1 (2022) | A systematic review of real-world clinical practice data in COVID-19: non-interventional studies | Abstract similar documents |
| S. A. Mishinova, Yu. M. Gomon, A. S. Kolbin, V. V. Strizheletsky, I. G. Ivanov | ||
| "... Введение. По определению, данному Food and Drug Administration, данные реального мира (англ. real ..." | ||
| Vol 16, No 2 (2023) | Molecular pharmacology of coenzyme Q10 in the context of treatment of hyperlipidemic conditions | Abstract similar documents |
| O. A. Gromova, I. Yu. Torshin | ||
| "... ингибирования статинами процессов биосинтеза кофактора коэнзим Q10 (англ. coenzyme Q10, CoQ10), играющего ..." | ||
| 1 - 50 of 80 Items | 1 2 > >> | |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
